Home LiteratureArticle Details
PMID: 48945 Published · ppublish English Journal Article

Infection caused by Proteus mirabilis strains with transferrable gentamicin-resistance factors.

Lancet (London, England) ·Vol. 1 ·No. 7921 ·1975-06-21 ·Pages 1355-7

Datta N

Abstract

During a period of 10 weeks, four patients in one hospital became infected with gentamicin-resistant Proteus mirabilis. In two of them septicaemia associated with indwelling catheters developed, one had urinary tract and wound infections, and in the fourth patient the organism was isolated from a superficial wound. The P. mirabilis strains showed multiple drug resistance. Strains form the first three patients were apparently identical and were sensitive to tobramycin. Their gentamicin resistance was not transferable to Escherichia coli K12, but could be transferred to another strain of P. mirablilis (PM13-3). The fourth strain was resistant to tobramycin; its gentamicin/tobramycin resistance was transferable to E. coli K12.

MeSH Terms
Anti-Bacterial Agents/pharmacology Cross Infection/microbiology Drug Resistance, Microbial Escherichia coli/drug effects Female Gentamicins/pharmacology,therapeutic use Humans Male Microbial Sensitivity Tests Middle Aged Proteus Infections/microbiology Proteus mirabilis/drug effects,isolation & purification Sepsis/drug therapy,etiology,microbiology Serotyping Tobramycin/pharmacology
Chemicals
Anti-Bacterial Agents Gentamicins Tobramycin
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Datta N
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
Published
1975-06-21
Pages
1355-7
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]